tykhr
sign in
free sign up
Aardvark Therapeutics, Inc. Common Stock
Biotechnology
Healthcare
AARD
21.69 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
11.40
52 week high
17.25
high
11.86
52 week low
0.00
low
11.26
growth
-20.06 %
previous Close
11.23
P/E ratio
market cap
284 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
-14.37 M
-54.32 %
eps
0.00 %
-63.69 %
eps surprise
2.60 %
net profit margin
-1436700000.00 %
0.00 %
operating incoming
-15.85 M
-51.37 %
net change in cash
-506.00 K
98.56 %
cash on hand
26.00 M
-1.91 %
cost of revenue
0.00 %
top